about
Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytesA Single N-Acetylgalactosamine Residue at Threonine 106 Modifies the Dynamics and Structure of Interferon 2a around the Glycosylation SiteESIprot: a universal tool for charge state determination and molecular weight calculation of proteins from electrospray ionization mass spectrometry dataCharacterization of the murine alpha interferon gene familyEffects of localized interactions and surface properties on stability of protein-based therapeutics.The biology of interferon-alpha and the clinical significance of anti-interferon antibodies.Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells.Interferon-alpha and the pathogenesis of myeloproliferative disorders.The human interferon alpha species and receptors.Preclinical studies on targeted delivery of multiple IFNα2b to HLA-DR in diverse hematologic cancers.Structural Characterization of Carbohydrates by Fourier Transform Tandem Mass Spectrometry.Expression of biologically active human recombinant interferon alpha 2b in human breast cancer cell line Bcap-37.Human leukocyte interferon alpha: structure, pharmacology, and therapeutic applications.Expression of human interferon-alpha 2 in Sf9 cells. Characterization of O-linked glycosylation and protein heterogeneities.Structure-activity of type I interferons.Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferasePeriplasmic expression of human interferon-alpha 2c in Escherichia coli results in a correctly folded molecule.Application of the broadband collision-induced dissociation (bbCID) mass spectrometry approach for protein glycosylation and phosphorylation analysis.Recombinant Proteins and Monoclonal Antibodies.High-yields and extended serum half-life of human interferon alpha2b expressed in tobacco cells as arabinogalactan-protein fusions.
P2860
Q24530642-FD091D07-8999-4AF1-824D-57F66D1CE378Q27675256-F6F76070-3752-4F20-A1A2-0BD3C0CA289EQ28269378-BF372CA9-5D3C-4B92-8D49-45C36E3EA305Q28588580-8A87EB4B-64F8-429E-960A-1043D9DECA72Q30395368-6199552D-07AA-4D98-86B8-F09EC2114C16Q30431132-89167FFB-4453-45BD-87E7-1B3EB74ED172Q33364273-619C8D21-1A59-402A-83F2-BE748397821EQ34103594-50B20CA1-BF4D-48F9-B5A3-CD1D967648B1Q34136286-D07C786A-A6B5-4F81-B8FC-333448B10060Q35172476-013D758F-588F-4318-B0D5-AEDC5F8AA4F1Q35786742-8251E223-F010-4577-B099-F979DDEAA205Q39105398-0DE4DD3A-2F90-4996-97A2-D921DF41D46AQ40928902-5A9F01E0-5F4B-4697-B147-40E83C21E38AQ41517464-062D3F0D-D957-48C6-89C8-2CBBCD1BC564Q41567642-3606BC5B-4613-45B4-8FCD-30F53956A2B1Q42091424-1FD2D16F-6812-4370-9BC8-DAAF0E9CD1E6Q42833083-19E08AC1-1FAE-4B03-B67A-488BB2BF8B9FQ47424613-3D744300-3D91-4BC0-B4F3-1F22F647AE94Q47602370-4DF5E243-65C7-4BE5-A1E3-0AD41BC44874Q51059213-F6FEFD79-4E64-4487-904D-1B5DA232B6D4
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Natural human interferon-alpha 2 is O-glycosylated
@ast
Natural human interferon-alpha 2 is O-glycosylated
@en
Natural human interferon-alpha 2 is O-glycosylated
@en-gb
Natural human interferon-alpha 2 is O-glycosylated
@nl
type
label
Natural human interferon-alpha 2 is O-glycosylated
@ast
Natural human interferon-alpha 2 is O-glycosylated
@en
Natural human interferon-alpha 2 is O-glycosylated
@en-gb
Natural human interferon-alpha 2 is O-glycosylated
@nl
prefLabel
Natural human interferon-alpha 2 is O-glycosylated
@ast
Natural human interferon-alpha 2 is O-glycosylated
@en
Natural human interferon-alpha 2 is O-glycosylated
@en-gb
Natural human interferon-alpha 2 is O-glycosylated
@nl
P2093
P2860
P356
P1433
P1476
Natural human interferon-alpha 2 is O-glycosylated
@en
P2093
P2860
P356
10.1042/BJ2760511
P407
P478
276 ( Pt 2)
P577
1991-06-01T00:00:00Z